Spasticity after stroke is managed through a combination of physical therapy, targeted injections, oral medications, and in severe cases, surgical interventions. Most stroke survivors develop some degree of spasticity within the first few weeks to months, and early treatment produces better long-term outcomes than waiting until muscles have already tightened significantly. The best approach depends on whether the spasticity is limited to one or two joints or spread across an entire side of the body.
What Causes Spasticity After Stroke
When a stroke damages the brain’s motor pathways, the normal signals that keep muscles relaxed and coordinated get disrupted. Muscles begin to fire involuntarily, resist being stretched, and sometimes lock into fixed positions. This isn’t just “tight muscles.” It’s a neurological problem where the brain can no longer properly regulate muscle tone.
Strokes that damage certain deep brain structures and the white matter tracts connecting them to the spinal cord are most likely to cause spasticity. Lesions involving the internal capsule, corona radiata, and basal ganglia carry the highest risk. The resulting symptoms fall on a spectrum: some people experience a slight catch when a limb is moved, while others develop rigid limbs that can’t be moved at all. Spasticity can also trigger painful spasms, involuntary clenching, and a phenomenon called spastic dystonia, where muscles hold a limb in an abnormal posture even at rest.
Spasticity is classified by how many areas it affects. Focal spasticity involves a single joint or region, like a clenched fist. Multifocal spasticity hits two or more joints. Hemispastic patterns affect the arm and leg on one side. Generalized spasticity involves more than two limbs and sometimes the jaw and trunk. This classification matters because focal and multifocal spasticity respond well to targeted injections, while widespread spasticity often requires systemic medications or surgical options.
How Spasticity Is Measured
Clinicians use the Modified Ashworth Scale to grade spasticity from 0 to 4. A score of 0 means normal muscle tone. A score of 1 means there’s a slight catch or minimal resistance when the limb is moved. At 2, resistance is noticeable through most of the range of motion but the limb still moves. At 3, passive movement becomes difficult. A score of 4 means the limb is completely rigid. Knowing where you or your family member falls on this scale helps guide which treatments are appropriate and provides a baseline for tracking whether interventions are working.
Stretching and Physical Therapy
Stretching is one of the most accessible tools for managing spasticity, but it works best as part of a broader program rather than on its own. The American Heart Association’s scientific statement on post-stroke spasticity notes that passive stretching alone is not effective as a standalone treatment and should be combined with other rehabilitation approaches.
That said, regular stretching still plays an important role. Static stretches held for 60 to 120 seconds primarily affect muscle tissue, while sustained stretches held for more than 10 minutes begin to influence tendons as well. One protocol that has shown benefit involves 90 seconds of static stretching repeated five times per session, which reduced muscle resistance in studies measuring passive stiffness and peak torque. After botulinum toxin injections (discussed below), patients are typically advised to perform at least 10 minutes of daily stretching to maximize the treatment’s effect.
Brief stretching routines alone may not change the underlying mechanical properties of spastic muscles. Research has shown that even 10 stretches of 45 seconds each, performed daily for three weeks, did not alter the structural properties of the muscle. This is why stretching needs to be paired with other interventions.
Task-Specific Training and Active Therapies
Several active rehabilitation approaches carry strong evidence for reducing spasticity’s functional impact. Task-specific training, where you practice real-world movements like reaching for objects or walking, improves motor control and has the highest level of evidence supporting its use. Constraint-induced movement therapy, which involves restricting the unaffected hand to force use of the affected one, works well for people who already have some movement in the affected arm. Functional electrical stimulation, which uses mild electrical pulses to activate weakened muscles during movement, enhances voluntary muscle activation, particularly in the lower limbs.
Early mobilization and weight-bearing activities help prevent the passive tissue changes that make spasticity worse over time. Starting these within the first three months after stroke helps prevent contractures and reduces overactive reflexes. Transcutaneous electrical nerve stimulation (TENS) has also shown effectiveness for lower limb spasticity, though its benefits for the upper limb are less clear. Extracorporeal shockwave therapy, where sound waves are directed at spastic muscles, produces short-term reductions in muscle tone.
Splints and Orthotics
Splinting helps maintain joint position and prevent the slow shortening of muscles and tendons that leads to contractures. For wrist and hand spasticity, custom-made static splints are commonly prescribed and typically worn overnight for up to 12 hours. These splints position the wrist in slight extension (around 0 to 10 degrees) to counteract the flexed posture that spastic muscles pull the hand into. Some patients use splints that position the wrist at greater than 45 degrees of extension with the fingers straightened, depending on the severity.
Ankle-foot orthoses serve a similar purpose for the lower limb, keeping the foot in a neutral position to improve walking and prevent the ankle from locking into a pointed-toe posture. The key with any orthotic is consistent use over weeks to months.
Botulinum Toxin Injections
For focal or multifocal spasticity, botulinum toxin injections are the treatment with the strongest evidence base. The toxin is injected directly into the overactive muscles, where it blocks the nerve signals causing them to contract. The effect typically lasts three to four months, after which the injections need to be repeated.
Most patients require injections every three to four months on an ongoing basis. Ultrasound guidance during injection improves accuracy and outcomes. Early use of botulinum toxin, ideally within the first few months after stroke, produces better results than waiting. The injections consistently reduce scores on the Modified Ashworth Scale, and when combined with a structured stretching and therapy program, the functional gains are significantly greater than with injections alone.
One challenge is that many patients don’t receive injections as frequently as guidelines recommend. A large French study found that fewer than 1% of patients who started botulinum toxin treatment received the recommended three injections within the first year.
Oral Medications
When spasticity is more widespread, oral medications can help reduce overall muscle tone. The two most commonly used are baclofen and tizanidine, and both work through different mechanisms in the nervous system.
Baclofen acts on receptors in the spinal cord that normally dampen nerve signaling, reducing the overactive stretch reflexes that drive spasticity. Tizanidine works by inhibiting the nerve pathways that facilitate muscle contraction, reducing both spasticity and the involuntary rhythmic contractions known as clonus. Tizanidine is typically started at a low dose and gradually increased over days to weeks based on response, with a goal of finding the lowest effective dose.
Both medications cause drowsiness and muscle weakness as side effects, which can be a significant trade-off. Reducing spasticity with oral drugs sometimes means reducing the muscle tone a person relies on for standing or walking. This is why oral medications are generally used when spasticity is widespread enough that targeted injections aren’t practical, or when spasticity is causing significant pain or interfering with care activities like dressing and hygiene. Neither medication should be stopped abruptly after prolonged use, as this can cause rebound spasticity and other withdrawal effects.
Intrathecal Baclofen Pumps
For people with severe, generalized spasticity that hasn’t responded to oral medications or injections, a surgically implanted baclofen pump delivers the drug directly into the fluid surrounding the spinal cord. This allows much smaller doses to reach the target area, which dramatically reduces the drowsiness and weakness that oral baclofen causes.
Candidates for this approach must first fail a six-week trial of less invasive treatments. Before implantation, a screening test is performed: a small dose of baclofen is injected into the spinal fluid via lumbar puncture, and the dose is gradually increased. If spasticity drops by at least two points on the Ashworth Scale for four to eight hours after the test dose, the patient is considered a good candidate. If there’s no response to the maximum test dose, implantation is not recommended.
The pump requires ongoing monitoring, periodic refills (done through a needle inserted into a port under the skin), and eventual surgical replacement when the battery runs out. Despite these demands, intrathecal baclofen carries Level A evidence for managing generalized post-stroke spasticity.
Selective Dorsal Rhizotomy
Selective dorsal rhizotomy is a surgical procedure that permanently reduces spasticity by cutting specific sensory nerve fibers entering the spinal cord. It is used selectively for lower extremity spasticity when other treatments have failed or produced intolerable side effects.
Though more commonly associated with cerebral palsy in children, the procedure has been performed successfully in adult stroke patients. In one reported case, a patient with a spasticity score of 4 out of 5 (near-complete rigidity) improved to 1 out of 5 after surgery, and this improvement held for over three years. In a larger study of 154 patients with various causes of spasticity, all showed improvement in lower limb spasticity at both early and late follow-up, and 20% of previously nonambulatory patients were able to walk after surgery. Other reported benefits include improved range of motion, bladder function, and even upper limb function.
Candidates are typically those for whom botulinum toxin injections and other conservative treatments have not provided adequate relief. The procedure is irreversible, so it’s reserved for cases where the pattern of spasticity is well established and unlikely to change.
Noninvasive Brain Stimulation
Repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) are newer approaches that target the brain directly. These techniques use magnetic pulses or weak electrical currents applied to the scalp to modulate activity in motor areas of the brain. Both have Level A evidence supporting their use for upper limb spasticity after stroke. Low-frequency rTMS applied to the unaffected side of the brain, and anodal tDCS applied to the affected side, have the strongest support. These treatments are typically administered in a clinical setting over a series of sessions and are used alongside physical therapy rather than as standalone treatments.
Timing Matters
One of the clearest messages from current evidence is that early intervention produces better outcomes. Starting active rehabilitation, weight-bearing exercises, and appropriate medical treatment within the first three months after stroke helps prevent the cascade of changes that make spasticity harder to treat later. Once muscles have shortened and soft tissues have stiffened, the problem shifts from a purely neurological one to a combination of nerve-driven spasticity and structural contracture, which is much harder to reverse. If you notice increasing stiffness, resistance to movement, or abnormal posturing in the weeks after a stroke, raising this with the rehabilitation team promptly gives you the widest range of effective options.